Matthew Jenusaitis - Sep 13, 2021 Form 4 Insider Report for Hancock Jaffe Laboratories, Inc. (NVNO)

Role
Director
Signature
/s/ Matthew Jenusaitis
Stock symbol
NVNO
Transactions as of
Sep 13, 2021
Transactions value $
$0
Form type
4
Date filed
9/15/2021, 09:50 PM
Previous filing
Aug 27, 2021
Next filing
Dec 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVNO Common Stock Options Exercise +1.04K +21.52% 5.88K Sep 13, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVNO Restricted Stock Units Options Exercise $0 -1.04K -33.33% $0.00 2.08K Sep 13, 2021 Common Stock 1.04K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") converts into one share of common stock of Hancock Jaffe Laboratories, Inc.
F2 On September 13, 2019, the reporting person was granted 3,125 RSUs (78,125 RSUs pre one-for-twenty five (1:25) reverse stock split that was effected in November 2020), subject to vesting and settlement as described in the person's Form 4, as filed on October 10, 2020. The vesting and settlement of 1,042 RSUs occurred on September 13, 2021